中国麻风皮肤病杂志 ›› 2023, Vol. 39 ›› Issue (9): 686-687.doi: 10.12144/zgmfskin202309686

• 病例报告 • 上一篇    下一篇

氨苯砜治疗麻风致粒细胞缺乏症一例

陈嘉惠   

  1. 佛山市顺德区慢性病防治中心皮肤科,广东佛山,528300
  • 出版日期:2023-09-15 发布日期:2023-09-05

Agranulocytosis caused by dapsone in the treatment of leprosy: a case report

CHEN Jiahui   

  1. Department of Dermatology, Foshan Shunde Chronic Disease Prevention Center, Foshan 528300, China
  • Online:2023-09-15 Published:2023-09-05

摘要: 本文报道一例氨苯砜治疗麻风致粒细胞缺乏症患者,本例患者HLA-B*1301基因检测结果为阴性,容易让医生忽视氨苯砜导致的药物不良反应,故此病例报道需引起皮肤科医生的警惕。

关键词: 麻风, 粒细胞缺乏症, 氨苯砜

Abstract: We report a case of agranulocytosis caused by dapsone in the treatment of leprosy. The result of HLA-B*1301 gene test in this patient was negative, which easily made doctors ignore the adverse drug reactions caused by dapsone. Therefore, the case report should alert dermatologists.

Key words: leprosy, agranulocytosis, dapsone